Sign in to view content

An Assessment of the Impact of Disease Activity Criteria on Dosing Interval Assignment in Clinical Trial Patients With nAMD

Marco A. Zarbin, MD, PhD

Video
Published 2023

Related

RAP Lesions
Thomas A. Ciulla, MD, MBA, FASRS
Retina Image Bank: Images of the Week
2014
Chronical Submacular Hemorrhage in the Setting of Neovascular AMD
Rita Couceiro, MD, MS
carlos marques-neves, MD, PhD, EBO
Retina Image Bank: Images of the Week
2015
Phase III Randomized Clinical Trial Comparing SB15 With Reference Aflibercept in Neovascular Age-Related Macular Degeneration 56-Week Results
Min Sagong, MD
Annual Meeting Talks
2023

Category: AMD-Neovascular

See more